Optimized management in patients with bladder cancer
Status PubMed-not-MEDLINE Jazyk angličtina Země Polsko Médium print
Typ dokumentu časopisecké články
PubMed
25914831
PubMed Central
PMC4408400
DOI
10.5173/ceju.2015.01.e93
PII: E93
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Cent European J Urol. 68:9-14. PubMed
Zobrazit více v PubMed
Poletajew S, Braticevici B, Brisuda A, Cauni V, Grygorenko V, Lesnyak M-Z, et al. Timing of radical cystectomy in Central Europe – multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients. Cent European J Urol. 2015;68:9–14. PubMed PMC
Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A. Longer Wait Times Increase Overall Mortality in Patients With Bladder Cancer. J Urol. 2009;182:1318–1324. PubMed
Nielsen ME, Palapattu GS, Karakiewicz PI, Lotan Y, Bastian PJ, Lerner SP, et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int. 2007;100:1015–1020. PubMed
Raj GV, Herr H, Serio AM, Donat SM, Bochner BH, Vickers AJ, Dalbagni G. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol. 2007;177:1283–1286. PubMed
Tomaszewski JJ, Handorf E, Corcoran AT, Wong YN, Mehrazin R, Bekelman JE, et al. Care Transitions between Hospitals Are Associated with Treatment Delay for Patients with Muscle Invasive Bladder Cancer. J Urol. 2014;192:1349–1354. PubMed PMC
Engilbertsson H, Aaltonen KE, Björnsson S, Kristmundsson T, Patschan O, Rydén L, Gudjonsson S. Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream. J Urol. 2015;193:53–57. PubMed